0 items

in your cart
$0.00

Drug Search > Treanda

Prescription Drug Search

Strengths available for Treanda vial:

Treanda vial 100mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Treanda:

  • Belarus
  • Belgium
  • Bermuda
  • Bosnia and Herzegovina
  • China
  • Cook Islands
  • Costa Rica
  • Croatia
  • Denmark
  • Dominican Republic
  • Ecuador
  • Estonia
  • Fiji
  • France
  • Georgia
  • Greece
  • Hungary
  • Iceland
  • India
  • Ireland
  • Jamaica
  • Japan
  • Korea, Republic of
  • Korea, South
  • Kuwait
  • Mauritius
  • Moldova, Republic of
  • Paraguay
  • Peru
  • Philippines
  • Portugal
  • Qatar
  • Russian Federation
  • Seychelles
  • Singapore
  • South Africa
  • Spain
  • Tonga
  • United Arab Emirates
  • United Kingdom, UK
View All Countries

Latest news releases on Treanda:

Teva reduces 2012 sales forecast - Marketwatch

The reduced forecast for branded drugs includes its outlook for leukemia drug Treanda and its women's health products. Teva recently reported its first-quarter profit jumped 41%, as strong sales of branded and generic medicines in the U.S. and ...

Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40 - StreetInsider.com

Brand product net sales of approximately $8.0 billion including estimated global net sales of the following products: -- COPAXONE® of $3.8 billion-- TREANDA® of $580 million-- Women’s Health products of $500 million-- ProAir® HFA of $430 million ...

Teva Issues 2012 Outlook - Analyst Blog - NASDAQ

Copaxone sales are expected to peak in 2012 and decline through 2015 with the entry of new competitors. Oncology product, Treanda (a part of Cephalon's portfolio), is expected to generate sales of $580 million. Sleep disorder drugs, Provigil and ...

What's Hot at ASCO This Year? - Medscape News

Bendamustine is a decades-old drug, but it was given a new lease on life in 2008 when it was approved (as Treanda, Cephalon) by the US Food and Drug Administration (FDA) for first-line use in chronic lymphocytic leukemia (CLL). However, the dose used in ...

Mixed Quarter from Teva - Zacks.com

Revenues benefited from the inclusion of Cephalon products – Provigil ($291 million), Treanda ($148 million) and Nuvigil ($84 million). Key branded product Copaxone posted global in-market sales of $941 billion, up 4%. Other products/segments that ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK